Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Aripiprazole NDC 50090-6563 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image 1 - image fig1 effectofofotherdrug arip

Image 1 - image fig1 effectofofotherdrug arip

Image 2 - image fig2 effectofotherdrug dehydroaripip

Image 2 - image fig2 effectofotherdrug dehydroaripip

Figure 2 shows the effect of other drugs on the pharmacokinetics of Dehydro-Aripiprazole. The text provides the names of some drugs and their potential impact on the metabolism of Aripiprazole. The drugs mentioned include teocorazoe AN, mnbtr, qundre e, YPom aucer, catanzmoe A bt, famoide P wr, and foracepam ¥. The text also mentions the percentage change in pharmacokinetics and relative reference values.*

image 3 - image fig3 effectofarip otherdrug

image 3 - image fig3 effectofarip otherdrug

Figure 3 shows the effect of Aripiprazole, a medication, on the pharmacokinetics (movement and breakdown in the body) of other drugs. The graph displays the fold change and 90% confidence intervals for various drugs, including demopmetorphan, rowarfarin, lamotrigine, valproate, litum, lorazepam, venlafaine, veniatasine, O-desmetnyheniataing, and escitalopram. The x-axis represents the change relative to the reference (without the interacting drug), ranging from 5 to 25. This information helps understand how Aripiprazole can affect the metabolism and levels of other medications in the body.*

Image 4 - image fig4 effectofintrinsicfactor arip

Image 4 - image fig4 effectofintrinsicfactor arip

image 5 - image fig5 effectofintrinsicfactor dehydroarip

image 5 - image fig5 effectofintrinsicfactor dehydroarip

fig 6 - image fig6 schizophreniastudy 5

fig 6 - image fig6 schizophreniastudy 5

Proportion with Relapse Figure 6 shows the Kaplan-Meier Estimation of the cumulative proportion of patients with relapse in Schizophrenia Study 5. The graph compares the relapse rates between the ARIPIPRAZOLE group and the PLACEBO group. The number of subjects at risk is indicated for each group at different time points. However, the specific numbers are not clearly readable due to possible errors.*

7 - image fig7 bipolarstudy 7

7 - image fig7 bipolarstudy 7

8 - image fig8 bipolarstudy 8

8 - image fig8 bipolarstudy 8

9 - image fig9 tourettesdisorderstudy1

9 - image fig9 tourettesdisorderstudy1

Image - image logo medguide

Image - image logo medguide

logo - image logo pi

logo - image logo pi

description image - image structure

description image - image structure

Label Image - lbl500906563

Label Image - lbl500906563

This is a description of a medication called ARIptpRAZOLE. It is available in a 5 MG strength and comes in a pack of 30 tablets. The product number is 6703-0. The medication is to be taken at a specific time, indicated as 8 10 7 Decces ¢, which is unclear.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.